| 1 |
2024 |
Saru Basnet, Mirte Van der Heijden, Dafne C.A. Quixabeira, Elise Jirovec, Susanna A.M. Grönberg-Vähä-Koskela, James H.A. Clubb, Anna Kanerva, Santeri Pakola, Lyna Haybout, Victor Arias, Otto Hemminki, Tatiana Kudling, Sadia Zafar, Victor Cervera-Carrascon, Joao M. Santos, Akseli Hemminki. Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine, Molecular Therapy. 2024; 32: 3114.
https://doi.org/10.1016/j.ymthe.2024.06.029 |
| 2 |
2023 |
In Kang, Yumin Kim, Heung Kyu Lee. γδ T cells as a potential therapeutic agent for glioblastoma, Frontiers in Immunology. 2023; 14: 1273986.
https://doi.org/10.3389/fimmu.2023.1273986 |
| 3 |
2024 |
Noah Eckman, Anahita Nejatfard, Romola Cavet, Abigail K. Grosskopf, Eric A. Appel. Biomaterials to enhance adoptive cell therapy, Nature Reviews Bioengineering. 2024; 2: 408.
https://doi.org/10.1038/s44222-023-00148-z |
| 4 |
2024 |
Ngoc Thien Thu Nguyen, Rasmus Müller, Daria Briukhovetska, Justus Weber, Judith Feucht, Annette Künkele, Michael Hudecek, Sebastian Kobold. The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity, Cancers. 2024; 16: 2608.
https://doi.org/10.3390/cancers16142608 |
| 5 |
2024 |
Christophe Richez, CAR-T cell en rhumatologie, Revue du Rhumatisme. 2024; 91: A8.
https://doi.org/10.1016/j.rhum.2024.10.003 |
| 6 |
2023 |
Ying Fang, Yichen Zhu, Adam Kramer, Yuning Chen, Yan-Ruide Li, Lili Yang. Graft-versus-Host Disease Modulation by Innate T Cells, International Journal of Molecular Sciences. 2023; 24: 4084.
https://doi.org/10.3390/ijms24044084 |
| 7 |
2024 |
Adishwar Rao, Akriti Agrawal, Gautam Borthakur, Venkata Lokesh Battula, Abhishek Maiti. Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies, Journal for ImmunoTherapy of Cancer. 2024; 12: e007981.
https://doi.org/10.1136/jitc-2023-007981 |
| 8 |
2024 |
Caroline Diorio, David T. Teachey, Stephan A. Grupp. Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks, Nature Reviews Clinical Oncology. 2024;
https://doi.org/10.1038/s41571-024-00959-y |
| 9 |
2023 |
Claudia Giannotta, Federica Autino, Massimo Massaia. Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?, Frontiers in Immunology. 2023; 14: 1167443.
https://doi.org/10.3389/fimmu.2023.1167443 |
| 10 |
2024 |
Joanna Chojnacka-Purpurowicz, Agnieszka Owczarczyk-Saczonek, Bogusław Nedoszytko. The Role of Gamma Delta T Lymphocytes in Physiological and Pathological Condition—Focus on Psoriasis, Atopic Dermatitis, Autoimmune Disorders, Cancer and Lymphomas, International Journal of Molecular Sciences. 2024; 25: 7960.
https://doi.org/10.3390/ijms25147960 |
| 11 |
2022 |
Marta Sanz, Brendan T. Mann, Alisha Chitrakar, Natalia Soriano-Sarabia. Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches, Cells. 2022; 11: 3572.
https://doi.org/10.3390/cells11223572 |
| 12 |
2023 |
Léa Rimailho, Carla Faria, Marcin Domagala, Camille Laurent, Christine Bezombes, Mary Poupot. γδ T cells in immunotherapies for B-cell malignancies, Frontiers in Immunology. 2023; 14: 1200003.
https://doi.org/10.3389/fimmu.2023.1200003 |
| 13 |
2024 |
Sridevi Rajeeve, Abhinav Hoskote, Sham Mailankody. Accelerating accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?, Seminars in Hematology. 2024; 61: 297.
https://doi.org/10.1053/j.seminhematol.2024.09.001 |
| 14 |
2024 |
Jiapei Yuan, Jingliao Zhang, Beibei Zhao, Fang Liu, Tianfeng Liu, Yongjuan Duan, Yumei Chen, Xiaojuan Chen, Yao Zou, Li Zhang, Ye Guo, Wenyu Yang, Yang Yang, Jun Wei, Xiaofan Zhu, Yingchi Zhang. Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia, Cancer Letters. 2024; 596: 217018217018.
https://doi.org/10.1016/j.canlet.2024.217018 |
| 15 |
2022 |
Rama Rao Malla, Priyamvada Bhamidipati.
γδ T Cell-Mediated Immune Responses for Cancer Therapy: Special Focus on Breast Cancer
, Critical Reviews in Immunology. 2022; 42: 9.
https://doi.org/10.1615/CritRevImmunol.2023047363 |
| 16 |
2024 |
Megan Yuan, Wenjun Wang, Isobel Hawes, Junwen Han, Zhenyu Yao, Alice Bertaina. Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy, Frontiers in Immunology. 2024; 15: 1360237.
https://doi.org/10.3389/fimmu.2024.1360237 |
| 17 |
2024 |
Georg Schett, Fabian Müller, Jule Taubmann, Andreas Mackensen, Wei Wang, Rich A. Furie, Ralf Gold, Aiden Haghikia, Peter A. Merkel, Roberto Caricchio, Maria-Antonietta D’Agostino, Franco Locatelli, Carl H. June, Dimitrios Mougiakakos. Advancements and challenges in CAR T cell therapy in autoimmune diseases, Nature Reviews Rheumatology. 2024; 20: 531.
https://doi.org/10.1038/s41584-024-01139-z |
| 18 |
2024 |
Caroline Lonez, Eytan Breman. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?, Cells. 2024; 13: 146.
https://doi.org/10.3390/cells13020146 |
| 19 |
2023 |
Derek Lee, Zachary Spencer Dunn, Wenbin Guo, Carl J. Rosenthal, Natalie E. Penn, Yanqi Yu, Kuangyi Zhou, Zhe Li, Feiyang Ma, Miao Li, Tsun-Ching Song, Xinjian Cen, Yan-Ruide Li, Jin J. Zhou, Matteo Pellegrini, Pin Wang, Lili Yang. Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering, Nature Communications. 2023; 14: 6942.
https://doi.org/10.1038/s41467-023-42619-2 |
| 20 |
2023 |
John Anderson, Marta Barisa. Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers, Molecular Therapy - Oncolytics. 2023; 30: 151.
https://doi.org/10.1016/j.omto.2023.08.003 |
| 21 |
2024 |
Andrew P Jallouk, Salyka Sengsayadeth, Bipin N Savani, Bhagirathbhai Dholaria, Olalekan Oluwole. Allogeneic and other innovative chimeric antigen receptor platforms, Clinical Hematology International. 2024; 6:
https://doi.org/10.46989/001c.121404 |
